{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:20:28Z","timestamp":1719534028975},"posted":{"date-parts":[[2024,6,25]]},"group-title":"In Review","reference-count":31,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,6,5]]},"abstract":"<title>Abstract<\/title>\n        <p>Background\n According to the Centers for Disease Control (CDC), breast cancer is the second most common cancer among women in the United States. Affected people are financially challenged due to the high out-of-pocket cost of breast cancer treatment, as it is the most expensive treatment. Using a 16-year cohort study of breast cancer survival data in Texas, we investigate the factors that might explain why some breast cancer patients live longer than others.\nMethods\n Performing a survival analysis consisting of the log-rank test, a survival time regression, and Cox proportional hazards regression, we explore the breast cancer survivors\u2019 specific attributes to identify the main determinants of survival time.\nResults\n Analyses show that the factors: stage, grade, primary site of the cancer, number of cancers each patient has, histology of the cancer, age, race, and income are among the main variables that enlighten why some breast cancer survivors live much longer than others. For instance, compared to White non-Hispanics, Black non-Hispanics have a shorter length of survival with a hazard ratio of (1.282). The best prognostic for White non-Hispanics, Hispanics (all races), and Black non-Hispanics is a woman aged between 40 to 49 years old, diagnosed with localized stage and grade one with Axillary tail of breast as a primary site with only one cancer and with a household income of 75,000.00 and over.\nConclusion\n Policymakers should promote early diagnosis and screening and better assist the older and the poor to improve the survival time for breast cancer patients.<\/p>","DOI":"10.21203\/rs.3.rs-4535192\/v1","type":"posted-content","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T20:59:59Z","timestamp":1719349199000},"source":"Crossref","is-referenced-by-count":0,"title":["Unraveling the Influence of Social, Economic, and Demographic Factors in Texas on Breast Cancer Survival"],"prefix":"10.21203","author":[{"given":"Sidketa Ida","family":"Fofana","sequence":"first","affiliation":[{"name":"University of Texas Rio Grande Valley"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer","family":"Oraby","sequence":"additional","affiliation":[{"name":"University of Texas Rio Grande Valley"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Everado","family":"Cobos","sequence":"additional","affiliation":[{"name":"ISU, University of Texas Rio Grande Valley"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish K.","family":"Tripathi","sequence":"additional","affiliation":[{"name":"ISU, University of Texas Rio Grande Valley"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8761","reference":[{"key":"ref1","unstructured":"CDC: United States Cancer Statistics (2023) Data Visualizations. In.: https:\/\/gis.cdc.gov\/Cancer\/USCS\/#\/Trends\/"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel RL","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. Cancer J Clin 74(1):12\u201349","journal-title":"Cancer J Clin"},{"key":"ref3","author":"Financial Burden of Cancer Care","year":"2023","unstructured":"Financial Burden of Cancer Care (2023) In : https:\/\/progressreport.cancer.gov\/after\/economic_burden#field_additional_information","journal-title":"In"},{"key":"ref4","article-title":"Cancer, by Tumor Stage and Type of Service","author":"Comparison of Treatment Costs for Breast","year":"2016","unstructured":"Comparison of Treatment Costs for Breast (2016) Cancer, by Tumor Stage and Type of Service. AM Health Drug Benefits Feb","journal-title":"AM Health Drug Benefits Feb"},{"key":"ref5","unstructured":"Breast Cancer (2022) In.: https:\/\/www.dshs.texas.gov\/texas-cancer-registry\/cancer-statistics\/breast-cancer#:~:text=In%202022%2C%20an%20estimated%2019%2C921,death%20among%20women%20in%20Texas."},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s41232-022-00208-8","article-title":"Inflammation-associated premetastatic niche formation","volume":"42","author":"Deguchi A","year":"2022","unstructured":"Deguchi A, Maru Y (2022) Inflammation-associated premetastatic niche formation. Inflamm regeneration 42(1):22","journal-title":"Inflamm regeneration"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-981-32-9620-6_9","article-title":"Breast Cancer Metastasis","volume":"1187","author":"Kim MY","year":"2021","unstructured":"Kim MY (2021) Breast Cancer Metastasis. Adv Exp Med Biol 1187:183\u2013204","journal-title":"Adv Exp Med Biol"},{"issue":"21","key":"ref8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115625","article-title":"Organ-Specificity of Breast Cancer Metastasis","volume":"24","author":"Ibragimova MK","year":"2023","unstructured":"Ibragimova MK, Tsyganov MM, Kravtsova EA, Tsydenova IA, Litviakov NV (2023) Organ-Specificity of Breast Cancer Metastasis. Int J Mol Sci 24(21)","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"111450","DOI":"10.1016\/j.biopha.2021.111450","article-title":"The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges","volume":"138","author":"Xie S","year":"2021","unstructured":"Xie S, Wu Z, Qi Y, Wu B, Zhu X (2021) The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges. Biomed pharmacotherapy = Biomedecine pharmacotherapie 138:111450","journal-title":"Biomed pharmacotherapy = Biomedecine pharmacotherapie"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12032-020-01447-w","article-title":"Steps in metastasis: an updated review","volume":"38","author":"Majidpoor J","year":"2021","unstructured":"Majidpoor J, Mortezaee K (2021) Steps in metastasis: an updated review. Med Oncol (Northwood Lond Engl) 38(1):3","journal-title":"Med Oncol (Northwood Lond Engl)"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00109-013-1021-5","article-title":"The metastasis-promoting roles of tumor-associated immune cells","volume":"91","author":"Smith HA","year":"2013","unstructured":"Smith HA, Kang Y (2013) The metastasis-promoting roles of tumor-associated immune cells. J Mol Med 91(4):411\u2013429","journal-title":"J Mol Med"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1096\/fba.2021-00079","article-title":"Tumor extracellular vesicles drive metastasis (it's a long way from home)","volume":"3","author":"Ghoroghi S","year":"2021","unstructured":"Ghoroghi S, Mary B, Asokan N, Goetz JG, Hyenne V (2021) Tumor extracellular vesicles drive metastasis (it's a long way from home). FASEB bioAdvances 3(11):930\u2013943","journal-title":"FASEB bioAdvances"},{"key":"ref13","unstructured":"13 In.: (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Plus Limited-Field Data, 22 Registries, Nov 2022 Sub (2000\u20132020) - Linked to County Attributes - Time Dependent (1990\u20132021) Income\/Rurality, 1969\u20132021 Counties, National Cancer Institute,; April,2023"},{"key":"ref14","unstructured":"Breast Cancer (2023) In.: https:\/\/www.cdc.gov\/cancer\/breast\/basic_info\/risk_factors.htm"},{"issue":"4","key":"ref15","first-page":"226","volume":"9","author":"Study of Treatment and Risk Factors Leading to Breast Cancer","year":"2017","unstructured":"Study of Treatment and Risk Factors Leading to Breast Cancer (2017) Isra Med J Jul\/Aug 9(4):226\u2013228","journal-title":"Isra Med J Jul\/Aug"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Breast Cancer: Magnitude of the Problem and Descriptive Epidemiology. In.: Epidemiologic Reviews, Volume 15, Issue 1 (1993) Pages 7\u201316,; 1993","DOI":"10.1093\/oxfordjournals.epirev.a036118"},{"key":"ref17","author":"Mammograms","year":"2023","unstructured":"Mammograms (2023) February,. In.: https:\/\/www.cancer.gov\/types\/breast\/mammograms-fact-sheet#:~:text=In%20cancer%20screening%2C%20a%20negative,at%20the%20time%20of%20screening."},{"key":"ref18","article-title":"2000\u20132020","volume":"2008","author":"Productivity costs of cancer mortality in the United States","unstructured":"Productivity costs of cancer mortality in the United States 2000\u20132020. J Natl Cancer Inst Dec, 2008:100, Issue 124","journal-title":"J Natl Cancer Inst Dec"},{"key":"ref19","first-page":"286","article-title":"Cancer Among Survivors Aged 18\u201344 Years","volume":"50","author":"Productivity Costs Associated With Breast","unstructured":"Productivity Costs Associated With Breast Cancer Among Survivors Aged 18\u201344 Years. Am J Prev Med Feb 2016:Volume 50, Issue 52, Pages 286\u2013294","journal-title":"Am J Prev Med Feb 2016:Volume"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Increasing disparities in breast cancer mortality from 1979 to 2010 for US black women aged 20 to 49 years. American Journal of Public Health (2015) :105 Suppl 103(Suppl 103):S446-108. doi: 110.2105\/AJPH.2014.302297. Epub 302015 Apr 302223. PMID: 25905842; PMCID: PMC24455497","DOI":"10.2105\/AJPH.2014.302297"},{"key":"ref21","unstructured":"Racial differences in breast cancer stage at diagnosis in the mammography era. Am J Public Health (2013) :103(101):170\u2009\u2013\u2009106. doi: 110.2105\/AJPH.2011.300550. Epub 302012 Jun 300514. PMID: 22698058; PMCID: PMC23518347"},{"key":"ref22","unstructured":"Racial differences in survival from breast cancer. Results of the National Cancer Institute Black\/White Cancer Survival Study. JAMA (1994) :272(212):947\u2009\u2013\u2009254. doi: 210.1001\/jama.1272.1012.1947. PMID: 8084062"},{"key":"ref23","article-title":"and Improved Survival Among Medicare HMO Patients with Breast Cancer","author":"Earlier Stage at Diagnosis","unstructured":"Earlier Stage at Diagnosis and Improved Survival Among Medicare HMO Patients with Breast Cancer. J women's health 2010:Vol 19 19.","journal-title":"J women's health 2010:Vol"},{"key":"ref24","unstructured":"Investigating reasons for ethnic inequalities in breast cancer survival in New Zealand. Ethn Health (2011) :535\u2013549. doi: 510.1080\/13557858.13552011.13583638. Epub 13552011 Jun 13557853. PMID: 21644117"},{"key":"ref25","unstructured":"The relation between survival and age at diagnosis in breast cancer. The New England Journal of Medicine (1986) :315(319):559\u2009\u2013\u2009363. doi: 310.1056\/NEJM198608283150906. PMID: 198608283736639"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1200\/JCO.2004.04.173","volume":"22","author":"Functional impact of breast cancer by age at diagnosis","year":"2004","unstructured":"Functional impact of breast cancer by age at diagnosis (2004) J Clin Oncol May 22(10):1849\u20131856 doi: 1810.1200\/JCO.2004.1804.1173. PMID: 15143077","journal-title":"J Clin Oncol May"},{"key":"ref27","author":"Santorelli MLHK","year":"2017","unstructured":"Santorelli MLHK, Steinberg MB, Lin Y, Rhoads GG, Bandera EV, Demissie K (2017) Racial differences in the effects of comorbidity on breast cancer-specific survival. Cancer Causes Control August, :(8):809\u2013817. doi: 810.1007\/s10552-10017-10915-x. Epub 12017 Jun 10522. PMID: 28643109"},{"key":"ref28","author":"Obesity physical","unstructured":"Obesity physical activity, and breast cancer survival among older breast cancer survivors in the Cancer Prevention Study-II Nutrition Cohort. Breast Cancer Res Treat 2017:167(161):133\u2013145. doi: 110.1007\/s10549-10017-14470-10547. Epub 12017 Aug 10531. PMID: 28856470"},{"key":"ref29","author":"Obesity ethnicity","year":"2016","unstructured":"Obesity ethnicity (2016) and quality of life among breast Cancer survivors and women without breast cancer: the long-term quality of life follow-up study. Cancer Causes Control January, :(1):115\u2013124. doi: 110.1007\/s10552-10015-10688-z. Epub 12015 Oct 10530. PMID: 26518195; PMCID: PMC24871242"},{"key":"ref30","author":"Survival Rates for Breast Cancer","year":"2023","unstructured":"Survival Rates for Breast Cancer (2023) In.: https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/understanding-a-breast-cancer-diagnosis\/breast-cancer-survival-rates.html; March","journal-title":"March"},{"key":"ref31","article-title":"area poverty rate and site-specific cancer incidence in the United States","author":"The relationship between","year":"2014","unstructured":"The relationship between (2014) area poverty rate and site-specific cancer incidence in the United States. Cancer May","journal-title":"Cancer May"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4535192\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4535192\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T14:12:29Z","timestamp":1719497549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4535192\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":31,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4535192\/v1","relation":{},"subject":[],"published":{"date-parts":[[2024,6,25]]},"subtype":"preprint"}}